Inflammatory Cytokine Quantification in Infants
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01155830 |
Recruitment Status :
Completed
First Posted : July 2, 2010
Results First Posted : May 4, 2015
Last Update Posted : May 4, 2015
|
Sponsor:
University of Utah
Information provided by:
University of Utah
- Study Details
- Tabular View
- Study Results
- Disclaimer
- How to Read a Study Record
Study Type | Observational |
---|---|
Study Design | Observational Model: Cohort; Time Perspective: Prospective |
Conditions |
Sepsis Congenital Diaphragmatic Hernia Neonatal Cardiopulmonary Failure |
Enrollment | 21 |
Participant Flow
Recruitment Details | |
Pre-assignment Details |
Arm/Group Title | Infants With CHD | Infants With Sepsis | Infants Treated With ECMO |
---|---|---|---|
![]() |
Infants with Congenital Diaphragmatic Hernia (CHD) | Infants who are culture positive for sepsis and require vasopressor support | Infants suffering cardiopulmonary failure significant enough to require heart/lung bypass treatment with extracorporeal membrane oxygenation (ECMO) |
Period Title: Overall Study | |||
Started | 0 | 0 | 21 |
Completed | 0 | 0 | 21 |
Not Completed | 0 | 0 | 0 |
Baseline Characteristics
Arm/Group Title | Infants With CHD | Infants With Sepsis | Infants Treated With ECMO | Total | |
---|---|---|---|---|---|
![]() |
Infants with Congenital Diaphragmatic Hernia (CHD) | Infants who are culture positive for sepsis and require vasopressor support | Infants suffering cardiopulmonary failure significant enough to require heart/lung bypass treatment with extracorporeal membrane oxygenation (ECMO) | Total of all reporting groups | |
Overall Number of Baseline Participants | 0 | 0 | 21 | 21 | |
![]() |
[Not Specified]
|
||||
Age, Categorical
Measure Type: Number Unit of measure: Participants |
Number Analyzed | 0 participants | 0 participants | 21 participants | 21 participants |
<=18 years | 21 | 21 | |||
Between 18 and 65 years | 0 | 0 | |||
>=65 years | 0 | 0 | |||
Age, Continuous
Mean (Standard Deviation) Unit of measure: Days |
|||||
Number Analyzed | 0 participants | 0 participants | 21 participants | 21 participants | |
1 (1) | 1 (1) | ||||
Gender
Measure Type: Number Unit of measure: Participants |
Number Analyzed | 0 participants | 0 participants | 21 participants | 21 participants |
Female | 8 | 8 | |||
Male | 13 | 13 | |||
Region of Enrollment
Measure Type: Number Unit of measure: Participants |
|||||
United States | Number Analyzed | 0 participants | 0 participants | 21 participants | 21 participants |
21 | 21 |
Outcome Measures
Adverse Events
Limitations and Caveats
[Not Specified]
More Information
Results Point of Contact
Name/Title: | Dr. Christian Yost |
Organization: | University of Utah |
Phone: | 801/581-7052 |
EMail: | christian.yost@hmbg.utah.edu |
Responsible Party: | Dr. Donald Null, University of Utah |
ClinicalTrials.gov Identifier: | NCT01155830 |
Other Study ID Numbers: |
39121 |
First Submitted: | June 22, 2010 |
First Posted: | July 2, 2010 |
Results First Submitted: | December 10, 2014 |
Results First Posted: | May 4, 2015 |
Last Update Posted: | May 4, 2015 |